| |
| |
|
| Insider
Information: |
Clancy Paul J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,757,220 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,295 |
|
|
| Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INCY |
Incyte Corp |
Director |
– • – |
2021-09-30 |
4 |
A |
$68.78 |
$22,078 |
D/D |
321 |
7,621 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-12-31 |
4 |
A |
$73.40 |
$25,176 |
D/D |
343 |
7,964 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-03-31 |
4 |
A |
$79.42 |
$25,891 |
D/D |
326 |
8,290 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,606 |
11,102 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
10,434 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-06-30 |
4 |
A |
$75.97 |
$24,386 |
D/D |
321 |
10,755 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-09-30 |
4 |
A |
$66.64 |
$22,591 |
D/D |
339 |
11,094 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-12-30 |
4 |
A |
$80.32 |
$23,614 |
D/D |
294 |
11,388 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,599 |
14,701 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
14,211 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-06-30 |
4 |
A |
$62.25 |
$23,655 |
D/D |
380 |
14,591 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-09-29 |
4 |
A |
$57.77 |
$21,895 |
D/D |
379 |
14,970 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-12-29 |
4 |
A |
$62.79 |
$25,869 |
D/D |
412 |
15,382 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2024-03-28 |
4 |
A |
$56.97 |
$22,959 |
D/D |
403 |
15,785 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-02-12 |
4 |
AS |
$60.76 |
$58,397 |
D/D |
(958) |
30,173 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-02-12 |
4/A |
AS |
$60.76 |
$58,397 |
D/D |
(958) |
45,863 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-02-21 |
4 |
AS |
$60.05 |
$131,461 |
D/D |
(2,183) |
42,663 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-07-01 |
4 |
AS |
$56.01 |
$235,679 |
D/D |
(4,208) |
37,502 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2008-08-08 |
4 |
AS |
$50.66 |
$28,777 |
D/D |
(568) |
42,669 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2008-09-19 |
4 |
AS |
$50.00 |
$77,650 |
D/D |
(1,553) |
40,002 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-04-28 |
4 |
AS |
$98.75 |
$1,950,088 |
D/D |
(19,716) |
42,247 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2012-02-01 |
4 |
AS |
$120.00 |
$2,568,000 |
D/D |
(21,400) |
21,168 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-04-29 |
4 |
AS |
$219.71 |
$2,004,414 |
D/D |
(9,123) |
21,576 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-04-30 |
4 |
AS |
$222.57 |
$3,255,092 |
D/D |
(14,489) |
7,087 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-09-16 |
4 |
AS |
$236.94 |
$23,596,311 |
D/D |
(99,030) |
7,087 |
0 |
- |
|
119 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
